Mackenzie Financial Corp Has $2.80 Million Stock Holdings in Option Care Health, Inc. $OPCH

Mackenzie Financial Corp boosted its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 73.1% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 86,112 shares of the company’s stock after buying an additional 36,365 shares during the period. Mackenzie Financial Corp’s holdings in Option Care Health were worth $2,797,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the stock. Loomis Sayles & Co. L P lifted its position in Option Care Health by 3.3% during the second quarter. Loomis Sayles & Co. L P now owns 969,296 shares of the company’s stock worth $31,483,000 after acquiring an additional 30,829 shares during the last quarter. Teca Partners LP increased its stake in shares of Option Care Health by 5.8% during the second quarter. Teca Partners LP now owns 407,538 shares of the company’s stock worth $13,237,000 after purchasing an additional 22,385 shares during the period. Norges Bank acquired a new stake in Option Care Health during the 2nd quarter worth approximately $69,932,000. Hsbc Holdings PLC lifted its holdings in Option Care Health by 229.6% during the 2nd quarter. Hsbc Holdings PLC now owns 44,278 shares of the company’s stock worth $1,423,000 after purchasing an additional 30,846 shares during the last quarter. Finally, Aristides Capital LLC bought a new stake in Option Care Health in the 2nd quarter valued at $249,000. 98.05% of the stock is owned by institutional investors.

Insider Activity at Option Care Health

In other news, Director Norman L. Wright acquired 3,411 shares of the firm’s stock in a transaction that occurred on Tuesday, September 9th. The shares were acquired at an average cost of $29.31 per share, with a total value of $99,976.41. Following the completion of the purchase, the director directly owned 15,501 shares of the company’s stock, valued at $454,334.31. The trade was a 28.21% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of the business’s stock in a transaction on Monday, November 3rd. The shares were acquired at an average price of $25.98 per share, with a total value of $987,240.00. Following the completion of the purchase, the director directly owned 413,390 shares of the company’s stock, valued at approximately $10,739,872.20. The trade was a 10.12% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Company insiders own 0.64% of the company’s stock.

Option Care Health Trading Down 1.2%

Shares of Option Care Health stock opened at $29.90 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.56 and a debt-to-equity ratio of 0.85. Option Care Health, Inc. has a 12-month low of $22.29 and a 12-month high of $35.53. The company has a market capitalization of $4.75 billion, a price-to-earnings ratio of 23.73, a PEG ratio of 2.14 and a beta of 0.80. The firm’s 50-day moving average price is $28.20 and its two-hundred day moving average price is $29.37.

Analysts Set New Price Targets

Several research firms have weighed in on OPCH. JMP Securities set a $36.00 price objective on Option Care Health in a research report on Friday, October 31st. Cowen initiated coverage on shares of Option Care Health in a research report on Thursday, October 2nd. They set a “hold” rating on the stock. Barrington Research reiterated an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Friday, October 31st. Citigroup restated an “outperform” rating on shares of Option Care Health in a research report on Friday, October 31st. Finally, TD Cowen lowered their target price on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a report on Monday, November 3rd. Nine analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $35.67.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.